SHARES OF CORCEPT THERAPEUTICS FALL 34.5% PREMARKET AFTER US FDA DECLINES TO APPROVE CO'S DRUG FOR RARE HORMONAL DISORDER

Reuters · 12/31/2025 13:23

Please log in to view news